Agilus Diagnostics Explores UK Collaboration in Rapid Microbial Testing Technology

Agilus Diagnostics hosted the Rt Hon Douglas Alexander, Secretary of State for Scotland, and a Scottish delegation at its Goregaon facility in Mumbai to explore opportunities for collaboration in diagnostic technology and research. Facilitated by the British Deputy High Commission Mumbai, the visit highlighted Agilus Diagnostics’ laboratory capabilities and the potential of advanced microbial testing technologies in India. The engagement also focused on opportunities to introduce innovative diagnostic solutions to the Indian healthcare market and strengthen cooperation between Indian and Scottish healthcare technology companies.

Scottish Delegation Reviews Laboratory Capabilities

During the visit, Agilus Diagnostics presented an overview of its business operations and laboratory network. The programme also featured discussions on Edinburgh-based Microbira Limited’s plans for India, a demonstration of its rapid microbial testing technology and a walkthrough of the Microbiology Department at Agilus Diagnostics’ Goregaon facility, where the technology is installed. Rapid microbial testing can help identify infection-causing microorganisms and detect antimicrobial resistance (AMR). Consequently, these technologies could support faster diagnosis and more informed treatment decisions.

Also Read |  Supreme Court: Medical Negligence Requires Clear Evidence of Deviation from Accepted Practices

Agilus Diagnostics Highlights Opportunities for Technology Collaboration

Vijender Singh, Managing Director and Chief Executive Officer of Agilus Diagnostics, said India’s diagnostics sector offers significant opportunities for growth and innovation. He noted that engagement with international technology companies could help introduce advanced diagnostic capabilities to India and assess their suitability for local healthcare needs. The visit provided an opportunity to showcase Agilus Diagnostics’ expertise and discuss potential areas of collaboration.

Microbira Identifies Potential £10 Million Export Opportunity

The Scotland Office has highlighted a potential £10 million export opportunity for Microbira in the Indian diagnostics market. This reflects the growing scope for UK diagnostic technology companies to expand their presence in India. However, the commercial scope of any potential collaboration involving Agilus Diagnostics, including investment commitments, remains unfinalised. Douglas Alexander, Secretary of State for Scotland, emphasised the potential for India and Scotland to work together on antimicrobial resistance through research and innovation. He highlighted the visit as an opportunity to demonstrate how rapid microbial testing technology could contribute to faster infection diagnosis and support efforts to tackle AMR.

Also Read |  India’s Medical Device Sector Poised to Fill China’s Gap in US Market

Agilus Showcases Microbiology Expertise

Dr Deepak Sanghavi, Senior Vice President of Operations and Chief of the Mumbai Reference Lab at Agilus Diagnostics, said the visit enabled the company to demonstrate its microbiology capabilities and discuss emerging diagnostic technologies. He added that partnerships with international innovators could help evaluate solutions that address clinical needs while maintaining the quality standards and operational rigour required for diagnostic testing at scale.

UK–India Diagnostic Cohort Strengthens Industry Engagement

Separately, Agilus Diagnostics hosted nine UK diagnostics companies at its Goregaon facility on 26 October 2026 under the UK–India Diagnostic Cohort programme. The engagement provided participating companies with an opportunity to understand Agilus Diagnostics’ laboratory capabilities and explore potential areas for collaboration. As per the press release, through these initiatives, Agilus Diagnostics aims to strengthen relationships with international technology innovators and evaluate solutions that could advance diagnostic capabilities in India, particularly in microbial testing and antimicrobial resistance detection.

Also Read |  Ankura Hospital Saves Three-Year-Old Child with 60% Burns and Cardiac Arrest